Emcure plans to capture 25 per cent of the market for the drug as well as expand the market through this cheaper alternative to the innovator drug
Jeffrey Glazer and Jason Malek are also charged with rigging bids and price collusion
Regulator writes to the firm on 'significant violations' of manufacturing practices at the company' s Pune plant